Validation of fumonisin biomarkers in F344 rats
- 16 August 2007
- journal article
- Published by Elsevier in Toxicology and Applied Pharmacology
- Vol. 225 (1) , 28-39
- https://doi.org/10.1016/j.taap.2007.06.027
Abstract
No abstract availableKeywords
This publication has 53 references indexed in Scilit:
- Elevation of Sphinganine 1-Phosphate as a Predictive Biomarker for Fumonisin Exposure and Toxicity in MiceJournal of Toxicology and Environmental Health, Part A, 2006
- Serum sphinganine and the sphinganine to sphingosine ratio as a biomarker of dietary fumonisins during chronic exposure in ducksChemico-Biological Interactions, 2006
- Exposure to Fumonisins and the Occurrence of Neural Tube Defects along the Texas–Mexico BorderEnvironmental Health Perspectives, 2006
- Biologically active sphingolipids in cancer pathogenesis and treatmentNature Reviews Cancer, 2004
- Sphingosine 1-Phosphate, a Key Cell Signaling MoleculeJournal of Biological Chemistry, 2002
- Exposure of rural and urban populations in KwaZulu Natal, South Africa, to fumonisin B(1) in maize.Environmental Health Perspectives, 2001
- The determination of fumonisin B1in human faeces: a short term marker for assessment of exposureBiomarkers, 2000
- The cancer-promoting potential of fumonisin B1 in rat liver using diethylnitrosamine as a cancer initiatorCancer Letters, 1996
- Pilot study on the plasma pharmacokinetics of fumonisin B1 in cows following a single dose by oral gavage or intravenous administrationNatural Toxins, 1995
- Pharmacokinetic fate of 14C‐Labelled fumonisin B1 in SwineNatural Toxins, 1994